Home › Funds › Rock Springs Capital Management LP › ERAS
Rock Springs Capital Management LP position in ERAS
ERASCA INC · Health Care
Rock Springs Capital Management LP reported holding 1,405,393 shares of ERAS (ERASCA INC) in its Q3 2026 13F filing — a position valued at US$20.6M, representing 1.11% of its reported portfolio and ranking #25 among its reported holdings. Rock Springs Capital Management LP has disclosed ERAS holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Rock Springs Capital Management LP's ERAS position evolved
Rock Springs Capital Management LP first disclosed a stake in ERAS in Q4 2025 at 951,710 shares (US$3.5M). The position peaked in Q2 2026 at 1,402,150 shares, worth US$25.7M. Across 4 filings, Rock Springs Capital Management LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,405,393 shares valued at US$20.6M. Notable position changes include a 27% increase in Q2 2026 (shares fell 20% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 951.71K | $3.54M | New |
| Q1 2026 | 1.10M | $17.85M | Add |
| Q2 2026 | 1.40M | $25.69M | Add |
| Q3 2026 | 1.41M | $20.60M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ERAS and 13F data
ERAS (ERASCA INC) is a Health Care company. 73 other funds we track also report a position in ERAS — the largest reported positions include Frazier Life Sciences Management, L.P. (US$457.5M), RTW INVESTMENTS, LP (US$329.1M), Venrock Adviser, LLC (US$327.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ERAS
- Frazier Life Sciences Management, L.P. 24.98M sh · $457.55M · Q2 2026
- RTW INVESTMENTS, LP 22.45M sh · $329.07M · Q3 2026
- Venrock Adviser, LLC 17.89M sh · $327.78M · Q2 2026
- Siren, L.L.C. 13.20M sh · $193.48M · Q3 2026
- ARCH Venture Management, LLC 7.09M sh · $129.92M · Q2 2026
- Paradigm Biocapital Advisors LP 8.00M sh · $117.25M · Q3 2026
- Cormorant Asset Management, LP 6.00M sh · $109.92M · Q2 2026
- Affinity Asset Advisors, LLC 5.59M sh · $81.96M · Q3 2026
- Vivo Capital, LLC 4.02M sh · $58.94M · Q3 2026
- a16z Capital Management, L.L.C. 2.86M sh · $52.44M · Q2 2026
- Soleus Capital Management, L.P. 2.70M sh · $49.46M · Q2 2026
- EcoR1 Capital, LLC 2.95M sh · $43.25M · Q3 2026
More on Rock Springs Capital Management LP
FAQ
How long has Rock Springs Capital Management LP held ERAS?
Rock Springs Capital Management LP has disclosed ERAS holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Rock Springs Capital Management LP's current position in ERAS?
As of Q3 2026, Rock Springs Capital Management LP holds 1.41M shares of ERAS (ERASCA INC), valued at $20.60M, representing 1.11% of its reported portfolio and ranking #25.
Has Rock Springs Capital Management LP been buying or selling ERAS?
In the latest 13F filing (Q3 2026), Rock Springs Capital Management LP held unchanged its position in ERAS. The position peaked in Q2 2026 at 1.40M shares.
Which other funds hold ERAS?
Other major institutional holders of ERAS include Frazier Life Sciences Management, L.P., RTW INVESTMENTS, LP, Venrock Adviser, LLC, among 73 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.